De-isolation of patients with pulmonary tuberculosis after start of treatment - clear, unequivocal guidelines are missing

Eskild Petersen, Faryal Khamis, Giovanni Battista Migliori, Julie Glerup Bay, Ben Marais, Christian Wejse, Alimuddin Zumla

Research output: Contribution to journalReview article

Abstract

The study review guidelines on isolation of patients with tuberculosis, TB, from the World Health Organization, WHO, Centers for Disease Control and Prevention, CDC, and the European Center for Disease Control, ECDC. The review found that unequivocal guidelines for removing patients out of negative-pressure isolation and de-isolation patients from either single rooms or isolation at home is needed. Studies show that the time of effective treatment is the key parameter to follow to determine if patients are contagious to others or not. This means that standard treatment of multi-drug resistant, MDR, TB will not result in the patient being non-infectious. Thus it is important right from the time of diagnosis to know if the patient is infected with MDR TB or not. Thus the early use of molecular techniques to reveal drug susceptibility is important. Clear guidelines stating if patient with microscopy negative sputum no matter infected with fully susceptible or MDR TB, no matter HIV positive or not is needed.

Original languageEnglish
Pages (from-to)34-38
Number of pages5
JournalInternational Journal of Infectious Diseases
Volume56
DOIs
Publication statusPublished - Mar 2017

    Fingerprint

Keywords

  • Antitubercular Agents
  • Female
  • Humans
  • Internationality
  • Male
  • Patient Isolation
  • Practice Guidelines as Topic
  • Tuberculosis, Pulmonary
  • United States
  • World Health Organization
  • Journal Article
  • Review

Cite this